Allison B Rosen

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi The value of coronary heart disease care for the elderly: 1987-2002
    Allison B Rosen
    University of Michigan and Ann Arbor Veterans Affairs, USA
    Health Aff (Millwood) 26:111-23. 2007
  2. ncbi Patient adherence: a blind spot in cost-effectiveness analyses?
    Allison B Rosen
    Departments of Internal Medicine and Health Management and Policy, University of Michigan, 300 N Ingalls, Ste 7E10, Ann Arbor, MI 48109, USA
    Am J Manag Care 15:626-32. 2009
  3. pmc Challenges in building disease-based national health accounts
    Allison B Rosen
    Division of General Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
    Med Care 47:S7-13. 2009
  4. pmc A controlled trial of value-based insurance design - The MHealthy: Focus on Diabetes (FOD) trial
    Alicen Spaulding
    Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
    Implement Sci 4:19. 2009
  5. ncbi Quality of abstracts of papers reporting original cost-effectiveness analyses
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor Veterans Affairs Medical Center, Ann Arbor, MI 48109, USA
    Med Decis Making 25:424-8. 2005
  6. ncbi Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, 300 North Ingalls, Suite 7E10, Ann Arbor, MI 48109, USA
    Ann Intern Med 143:89-99. 2005
  7. ncbi Physicians' views of interventions to reduce medical errors: does evidence of effectiveness matter?
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, 300 North Ingalls, Suite 7C27, Ann Arbor, MI 48109, USA
    Acad Med 80:189-92. 2005
  8. pmc Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, Ann Arbor, MI 48109, USA
    J Gen Intern Med 21:315-9. 2006
  9. pmc Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis
    Michele Heisler
    Veterans Affairs Center for Clinical Practice Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI 48113 0170, USA
    Med Care 48:87-94. 2010
  10. ncbi Rising out-of-pocket costs in disease management programs
    Michael E Chernew
    University of Michigan, Ann Arbor, MI 48109 2029, USA
    Am J Manag Care 12:150-4. 2006

Detail Information

Publications33

  1. ncbi The value of coronary heart disease care for the elderly: 1987-2002
    Allison B Rosen
    University of Michigan and Ann Arbor Veterans Affairs, USA
    Health Aff (Millwood) 26:111-23. 2007
    ..Overall, the value of our CHD spending is quite good. Despite this wise investment of resources to date, considerable opportunities remain for additional investment to improve the adoption of valuable but underused health services...
  2. ncbi Patient adherence: a blind spot in cost-effectiveness analyses?
    Allison B Rosen
    Departments of Internal Medicine and Health Management and Policy, University of Michigan, 300 N Ingalls, Ste 7E10, Ann Arbor, MI 48109, USA
    Am J Manag Care 15:626-32. 2009
    ..Despite evidence that medication adherence can influence cost-effectiveness analysis (CEA) results, the extent to which published CEAs include adherence has not been fully characterized...
  3. pmc Challenges in building disease-based national health accounts
    Allison B Rosen
    Division of General Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
    Med Care 47:S7-13. 2009
    ..Measuring spending on diseases is critical to assessing the value of medical care...
  4. pmc A controlled trial of value-based insurance design - The MHealthy: Focus on Diabetes (FOD) trial
    Alicen Spaulding
    Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
    Implement Sci 4:19. 2009
    ..This program has the potential for broad dissemination to other employers and insurers wishing to improve the value of their health care spending...
  5. ncbi Quality of abstracts of papers reporting original cost-effectiveness analyses
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor Veterans Affairs Medical Center, Ann Arbor, MI 48109, USA
    Med Decis Making 25:424-8. 2005
    ..The authors examined the extent to which abstracts of published CEAs include key data elements (intervention, comparator, target population, study perspective) and assessed the effect of journal characteristics on reporting quality...
  6. ncbi Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, 300 North Ingalls, Suite 7E10, Ann Arbor, MI 48109, USA
    Ann Intern Med 143:89-99. 2005
    ..Angiotensin-converting enzyme (ACE) inhibitors slow renal disease progression and reduce cardiac morbidity and mortality in patients with diabetes. Patients' out-of-pocket costs pose a barrier to using this effective therapy...
  7. ncbi Physicians' views of interventions to reduce medical errors: does evidence of effectiveness matter?
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, 300 North Ingalls, Suite 7C27, Ann Arbor, MI 48109, USA
    Acad Med 80:189-92. 2005
    ..It further assessed whether academic affiliation was associated with physicians' ratings of effectiveness...
  8. pmc Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002
    Allison B Rosen
    Division of General Medicine, University of Michigan Health Systems, Ann Arbor, MI 48109, USA
    J Gen Intern Med 21:315-9. 2006
    ..Despite the marked benefit, it is unknown what percentage of patients with diabetes would benefit from and what percentage actually receive this preventive therapy...
  9. pmc Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis
    Michele Heisler
    Veterans Affairs Center for Clinical Practice Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI 48113 0170, USA
    Med Care 48:87-94. 2010
    ..Less is known about the extent to which such cost-related medication underuse is associated with increases in subsequent hospitalizations and deaths...
  10. ncbi Rising out-of-pocket costs in disease management programs
    Michael E Chernew
    University of Michigan, Ann Arbor, MI 48109 2029, USA
    Am J Manag Care 12:150-4. 2006
    ..To document the rise in copayments for patients in disease management programs and to call attention to the inherent conflicts that exist between these 2 approaches to benefit design...
  11. pmc Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?
    Kenneth M Langa
    Division of General Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA
    Alzheimers Dement 4:134-44. 2008
    ..To assess the impact of these multiple trends, we compared the prevalence and 2-year mortality of cognitive impairment (CI) consistent with dementia in the United States in 1993 to 1995 and 2002 to 2004...
  12. doi Impact of decreasing copayments on medication adherence within a disease management environment
    Michael E Chernew
    Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 27:103-12. 2008
    ..The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs...
  13. ncbi Views of practicing physicians and the public on medical errors
    Robert J Blendon
    Department of Health Policy and Management, Harvard School of Public Health, Boston 02115, USA
    N Engl J Med 347:1933-40. 2002
    ..What is not known is the level of support for these proposed changes among practicing physicians and the public...
  14. ncbi Do drug formulary policies reflect evidence of value?
    Peter J Neumann
    Department of Health Policy and Management and Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Manag Care 12:30-6. 2006
    ..To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs)...
  15. ncbi Medicare and cost-effectiveness analysis
    Peter J Neumann
    Department of Health Policy and Management and the Center for Risk Analysis, Harvard School of Public Health, Boston, USA
    N Engl J Med 353:1516-22. 2005
  16. pmc Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes
    Allison B Rosen
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    J Gen Intern Med 19:669-75. 2004
    ..Angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers (ARB) slow the progression of diabetic nephropathy, yet little is known about their use among patients at high risk for progression to ESRD...
  17. ncbi Growth and quality of the cost-utility literature, 1976-2001
    Peter J Neumann
    Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    Value Health 8:3-9. 2005
    ..This study updates and expands our previous work, which examined CUAs through 1997...
  18. ncbi Cost-utility analysis studies of depression management: a systematic review
    Paul A Pirraglia
    Rhode Island Hospital, 593 Eddy St, MPB 1, Providence, RI 02903, USA
    Am J Psychiatry 161:2155-62. 2004
    ....
  19. ncbi Diffusion of published cost-utility analyses in the field of health policy and practice
    Seema S Sonnad
    Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104 4283, USA
    Int J Technol Assess Health Care 21:399-402. 2005
    ..The diffusion of cost-utility analyses (CUAs) through the medical literature was examined, documenting visible patterns and determining how they correspond with expectations about the diffusion of process innovations...
  20. ncbi Variations in risk attitude across race, gender, and education
    Allison B Rosen
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Med Decis Making 23:511-7. 2003
    ..Little is known about the patient-specific factors that may contribute to this variation. This study examined variations in risk attitude across major sociodemographic groups...
  21. pmc Colorectal cancer screening disparities related to obesity and gender
    Allison B Rosen
    Department of Health and Management, Harvard School of Public Health, Beth Israel Deaconess Medical Center, Brigham and Womens Hospital, Boston, Massachusetts 02215, USA
    J Gen Intern Med 19:332-8. 2004
    ..Obese women are less likely to undergo breast and cervical cancer screening than nonobese women. It is not known whether obesity is associated with a lower likelihood of colorectal cancer screening...
  22. pmc Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis
    Dan Greenberg
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    BMJ 328:1536-7. 2004
  23. ncbi The impact of symptoms and impairments on overall health in US national health data
    Susan T Stewart
    Program for Health Systems Improvement, Harvard University, Cambridge, Massachusetts, USA
    Med Care 46:954-62. 2008
    ..To assess the effects on overall self-rated health of the broad range of symptoms and impairments that are routinely asked about in national surveys...
  24. ncbi Confronting hysteria: a reply to Fairman and Curtiss
    Michael E Chernew
    J Manag Care Pharm 14:324-6; author reply 326-8. 2008
  25. ncbi Linking cost sharing to value: an unrivaled yet unrealized public health opportunity
    R Scott Braithwaite
    Yale University School of Medicine and Veterans Affairs Connecticut Healthcare System, New Haven, Connecticut 06516, USA
    Ann Intern Med 146:602-5. 2007
    ..Systematic efforts to discourage inappropriate cost sharing may improve public health...
  26. ncbi Value-based insurance design
    Michael E Chernew
    Harvard University, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:w195-203. 2007
    ..This paper makes the case for VBID and outlines current VBID initiatives in the private sector as well as barriers to further adoption...
  27. ncbi Trends in cost effectiveness analyses in orthopaedic surgery
    Carmen A Brauer
    Department of Orthopaedic Surgery, British Columbia Children s Hospital, Vancouver, BC, Canada
    Clin Orthop Relat Res 457:42-8. 2007
    ....
  28. ncbi The value of medical spending in the United States, 1960-2000
    David M Cutler
    Department of Economics, Harvard University, and the National Bureau of Economic Research, Cambridge, Mass 02138, USA
    N Engl J Med 355:920-7. 2006
    ..The increased use of medical therapies has led to increased medical costs. To provide insight into the value of this increased spending, we compared gains in life expectancy with the increased costs of care from 1960 through 2000...
  29. ncbi Trends in the measurement of health utilities in published cost-utility analyses
    Carmen A Brauer
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA, USA
    Value Health 9:213-8. 2006
    ..tufts-nemc.org/cearegistry; previously at http://www.hsph.harvard.edu/cearegistry), and documents recent changes in methods used for utility weight elicitation...
  30. ncbi A synthesis of cost-utility analysis literature in infectious disease
    Patricia W Stone
    Columbia University School of Nursing, New York, NY 10032, USA
    Lancet Infect Dis 5:383-91. 2005
    ..The results of cost-utility analyses have important implications for the development of clinical guidelines and resource allocation decisions. More trained investigators and better peer-review processes are needed...
  31. ncbi Cost-utility analyses in orthopaedic surgery
    Carmen A Brauer
    Harvard Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    J Bone Joint Surg Am 87:1253-9. 2005
    ..We critically reviewed the literature on orthopaedic cost-utility analysis to determine which subspecialty areas are represented, the cost-utility ratios that have been utilized, and the quality of the present literature...
  32. ncbi Can we better prioritize resources for cost-utility research?
    Peter J Neumann
    Harvard School of Public Health, Boston, MA 02115, USA
    Med Decis Making 25:429-36. 2005
    ....
  33. pmc Bias in published cost effectiveness studies: systematic review
    Chaim M Bell
    St Michael s Hospital, Toronto, Ontario, Canada M5B 1W8
    BMJ 332:699-703. 2006
    ....